Philippe Devillier
← Back to Université de Versailles Saint-Quentin-en-Yvelines
Université de Versailles Saint-Quentin-en-Yvelines
Philippe Devillier works in Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Chronic Obstructive Pulmonary Disease (COPD) Research, Food Allergy and Anaphylaxis Research, Inhalation and Respiratory Drug Delivery. Recorded institutional associations include Inserm, Vilnius University, Université de Versailles Saint-Quentin-en-Yvelines.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
2012 · 626 citationsNext-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
2019 · 609 citationsIntranasal drug delivery: An efficient and non-invasive route for systemic administration
2012 · 428 citationsMild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations
2007 · 247 citationsMetabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study
2020 · 215 citationsImpact of Allergic Rhinitis Symptoms on Quality of Life in Primary Care
2012 · 205 citationsMACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
2015 · 201 citationsSublingual immunotherapy provides long‐term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real‐world database analysis
2017 · 184 citationsEarly onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber
2009 · 176 citationsIntegrated care pathways for airway diseases (AIRWAYS-ICPs)
2014 · 174 citationsVisual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care
2013 · 167 citationsAllergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology
2018 · 162 citationsARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
2016 · 160 citationsIntraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.
1996 · 158 citationsCharacterization of Neurokinin Effects and Receptor Selectivity in Human Isolated Bronchi
1989 · 151 citationsComparison of the effects of epithelium removal and of an enkephalinase inhibitor on the neurokinin‐induced contractions of guinea‐pig isolated trachea
1988 · 138 citationsMobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study
2019 · 136 citationsMASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence
2018 · 135 citationsSmall airways diseases, excluding asthma and COPD: an overview
2013 · 130 citationsGuidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma
2019 · 127 citationsNext-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases
2019 · 124 citationsmRNA expression of tachykinins and tachykinin receptors in different human tissues
2004 · 122 citationsTreatment of allergic rhinitis using mobile technology with real‐world data: The MASK observational pilot study
2018 · 121 citationsRhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis
2023 · 118 citationsA meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
2014 · 115 citationsPharmacological Characterization of Olodaterol, a Novel Inhaled β2-Adrenoceptor Agonist Exerting a 24-Hour-Long Duration of Action in Preclinical Models
2010 · 115 citationsPeptides and histamine release from rat peritoneal mast cells
1985 · 108 citationsPilot study of mobile phone technology in allergic rhinitis in European countries: the MASK ‐rhinitis study
2017 · 105 citationsThe Role of Toll-Like Receptors in the Production of Cytokines by Human Lung Macrophages
2018 · 105 citationsVascular Biology of the Isoprostanes
2001 · 104 citationsThe expression and relaxant effect of bitter taste receptors in human bronchi
2013 · 102 citationsThe Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study
2017 · 102 citationsAllergen exposure chambers: harmonizing current concepts and projecting the needs for the future – an EAACI Position Paper
2017 · 100 citationsAdherence to treatment in allergic rhinitis using mobile technology. The MASK Study
2018 · 99 citationsClinical Pharmacokinetics and Pharmacodynamics of Desloratadine, Fexofenadine and Levocetirizine
2008 · 95 citationsSmall airway impairment in moderate to severe asthmatics without significant proximal airway obstruction
2013 · 93 citationsWork productivity in rhinitis using cell phones: The MASK pilot study
2017 · 91 citationsPopulation pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass
2013 · 88 citationsUpdate on the roles of distal airways in COPD
2011 · 86 citationsBitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists
2019 · 86 citationsNasal response to substance P and methacholine in subjects with and without allergic rhinitis
1988 · 85 citationsDaily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study
2018 · 85 citationsReal-life assessment of the multidimensional nature of dyspnoea in COPD outpatients
2016 · 84 citationsRole of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptides
1989 · 83 citationsHouse dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma
2014 · 83 citationsA Practical Tranexamic Acid Dosing Scheme Based on Population Pharmacokinetics in Children Undergoing Cardiac Surgery
2013 · 79 citationsUpdate on the roles of distal airways in asthma
2009 · 79 citationsHow to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA2LEN statement
2011 · 78 citationsImatinib assay by HPLC with photodiode-array UV detection in plasma from patients with chronic myeloid leukemia: Comparison with LC-MS/MS
2009 · 78 citationsThromboxane A2and related prostaglandins in airways
1997 · 77 citations
